---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-083214"
form_type: "8-K"
ticker: "ACHV"
cik: "0000949858"
company_name: "ACHIEVE LIFE SCIENCES, INC."
filed_at: "2025-06-06T23:59:59+00:00"
generated_at: "2026-05-19T19:27:44.579615+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.4
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Achieve Life Sciences shareholders reject director equity plan increase

## Summary
- All seven director nominees elected with majority 'for' votes; broker non-votes 11,422,484.
- Ratification of PwC as auditor for FY2025 approved: 26,459,791 for, 53,879 against.
- Amendment to 2023 Non-Employee Director Equity Incentive Plan to increase shares failed: 6,736,105 for, 7,982,633 against.
- Proposal required majority of votes cast; failure may impact director compensation strategy.
- Broker non-votes (11,422,484) were not counted on non-routine matters, effectively against the plan.

## SEC filing metadata
- accession: 0000950170-25-083214
- form_type: 8-K
- ticker: ACHV
- cik: 0000949858
- company_name: ACHIEVE LIFE SCIENCES, INC.
- filed_at: 2025-06-06T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.4
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/949858/000095017025083214/0000950170-25-083214-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/949858/000095017025083214/achv-20250604.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-083214
- JSON: https://secwatch.observer/filing/0000950170-25-083214.json
- Plain text: https://secwatch.observer/filing/0000950170-25-083214.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.